Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Sponsor: Bluefin Biomedicine, Inc.
Summary
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Official title: A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients With Moderate to Severe Hidradenitis Suppurativa
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2025-11-03
Completion Date
2027-08-01
Last Updated
2026-04-03
Healthy Volunteers
No
Conditions
Interventions
BFB759
BFB759 is a human mAb that inhibits multiple pro-inflammatory cytokines that contribute to the pathogenesis of multiple disease processes characterized by aberrant inflammation, including hidradenitis suppurativa.
Placebo for BFB759
Placebo for BFB759
Locations (33)
Saguaro Dermatology
Phoenix, Arizona, United States
Encino Research Center
Encino, California, United States
Clinical Science Institute
Santa Monica, California, United States
Skin Care Research
Boca Raton, Florida, United States
Center for Skin Science and Innovation
Fort Lauderdale, Florida, United States
Ziaderm Research LLC
North Miami Beach, Florida, United States
Clinical Trials Management, LLC
Tampa, Florida, United States
DelRicht Research
Atlanta, Georgia, United States
Southeast Research Specialist LLC
Douglasville, Georgia, United States
The Indiana Clinical Trials Center, PC
Plainfield, Indiana, United States
DS Research of Kentucky
Louisville, Kentucky, United States
Martha Stewart
Mandeville, Louisiana, United States
Clinical Trials Management, LLC
Metairie, Louisiana, United States
DelRicht Research
New Orleans, Louisiana, United States
Oakland Hills Dermatology
Auburn Hills, Michigan, United States
MI Skin Innovations
Northville, Michigan, United States
DelRicht Research
Wildwood, Missouri, United States
JDR Dermatology Research LLC
Las Vegas, Nevada, United States
Skin Cancer and Dermatology Institute
Reno, Nevada, United States
Schweiger Dermatology, PC
Hackensack, New Jersey, United States
Equity Medical LLC
The Bronx, New York, United States
Optima Research - Boardman
Boardman, Ohio, United States
Apex Clinical Research Center, LLC
Canton, Ohio, United States
Apex Clinical Research Center, LLC
Mayfield Heights, Ohio, United States
UPMC Department of Dermatology
Pittsburgh, Pennsylvania, United States
Medical Univ of SC Department of Dermatology
Charleston, South Carolina, United States
DelRicht Research
Mt. Pleasant, South Carolina, United States
DelRicht Research
Smyrna, Tennessee, United States
DelRicht Research
Prosper, Texas, United States
Stryde Research-Epiphany Dermatology
Southlake, Texas, United States
Dermatology Specialists of Spokane
Spokane, Washington, United States
York Dermatology Clinical and Research Centre
Richmond Hill, Ontario, Canada
North York Research Inc.
Toronto, Ontario, Canada